AI Article Synopsis
- The antiphospholipid syndrome increases the risk of both arterial and venous blood clots due to the presence of specific antibodies.
- Arterial clots can cause serious complications like heart attacks, which can progress to severe heart failure.
- The text outlines a specific anticoagulation protocol for patients with this syndrome who are receiving an axial-flow left ventricle assist device called HeartMate II.
Article Abstract
The antiphospholipid syndrome is characterized by arterial and venous thrombosis and is associated with the presence of circulating antiphospholipid antibodies. Arterial thrombosis can result in myocardial infarction, which may potentially lead to end-stage heart failure. Here we report our anticoagulation protocol for patients with antiphospholipid syndrome that undergo axial-flow left ventricle assist devices (HeartMate II; Thoratec, Pleasanton, CA) implantation.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.athoracsur.2008.01.080 | DOI Listing |
Publication Analysis
Top Keywords
antiphospholipid syndrome
12
implantation left
4
left ventricular
4
ventricular assist
4
assist device
4
device patient
4
patient primary
4
antiphospholipid
4
primary antiphospholipid
4
syndrome antiphospholipid
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!